A double-blind, placebo-controlled trial of the efficacy and safety of two doses of azelastine hydrochloride in perennial allergic rhinitis

BACKGROUND: Azelastine hydrochloride (AZE) is a selective, non-sedating H1 antagonist with anti-inflammatory and mast cell stabilizing properties, which can be used as an alternative to intranasal corticosteroids. The objective of this study was to evaluate the efficacy of the new formulation of 0.1...

Descripción completa

Detalles Bibliográficos
Autores principales: Bousquet, Jean, Klimek, Ludger, Kuhl, Hans-Christian, Nguyen, Duc Tung, Ramalingam, Rajesh Kumar, Canonica, G. W., Berger, William E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Allergy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619846/
https://www.ncbi.nlm.nih.gov/pubmed/37920410
http://dx.doi.org/10.3389/falgy.2023.1244012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619846/
https://www.ncbi.nlm.nih.gov/pubmed/37920410
http://dx.doi.org/10.3389/falgy.2023.1244012

Ejemplares similares